32
Total investments
25
Early stage
1
Mid stage
0
Late stage
24y
Years active
Portfolio
29 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and Board Member
Oct 2024
Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models. Our proprietary dataset includes more than 100,000 molecules tested in pooled primary human liver cells, tens of thousands of molecules with pharmacokinetic measurements, and thousands of molecules with curated clinical outcome data. Axioms AI models offer higher accuracy than advanced in vitro systems like 3d spheroids, deep mechanistic understanding which untangles mitochondrial toxicity, ER stress, ROS formation, cytotoxicity, and more, and precise risk assessment for any molecule at relevant clinical dosage and clinical exposure levels. Our models remove the need for costly physical experiments, giving more accurate and cheaper toxicity assessments, and empowering scientists to make better-informed decisions and bring safer drugs to the clinic.
Investor and Board Member
Oct 2020
Your team is your best defense against attacks. Empower them to build safe, scalable access workflows.
Sym's approach to access management removes the pain of manual ticket queues and unmaintainable internal tools. Our low-code, DevOps-friendly workflow platform unlocks authorization tooling that is maintainable and highly customizable.
Investor and Board Member
May 2020
With Hex, anyone can explore data using natural language, with or without code, all on trusted context, in one AI-powered platform.
Investor and Board Member
Dec 2019
Einblick is the fastest and most collaborative way to explore data, create predictions, and deploy data apps.
The Einblick team has joined Databricks https://www.databricks.com/blog/welcome-data-intelligence-platform-databricks-einblick
Investor and Board Member
Jul 2019
System Initiative is a collaborative power tool designed to remove the papercuts from DevOps work.
Investor and Board Member
Dec 2018
Healthcare needs good data. At PicnicHealth, we are building deep real-world datasets fueling cutting edge research while giving patients control of their own medical record data. These complete, clinically-rich datasets produce unique insights - across dozens of diseases - to ultimately get the right treatments into patients’ hands faster. We do this by working directly with patients and leveraging state of the art machine learning and human curation to transform messy medical records into structured, research-ready datasets. To date, we’ve helped tens of thousands of patients securely access their records and proactively contribute to advancing research in diseases that impacts their lives.
We partner with some of the largest life sciences companies (including 10 of the Top 30) and have raised more than $100M including a recently closed $60M Series C led by B Capital Group, with continued investments from Felicis Ventures and Amplify Partners, who also participated in the Series B.
Investor
Dec 2018
InterVenn was co-founded by Nobel Laureate Dr. Carolyn Bertozzi, world-class scientist, and distinguished professor Dr. Carlito Lebrilla and leading AI/ML expert Aldo Carrascoso on the belief that no one should ever be blindsided by disease.
We are focused on decoding the glycoproteome as a rich source of biological insight. Thanks to the use of artificial intelligence (AI), we have pioneered a proprietary technology platform, GlycoVision™, to tap into this layer of biology at a clinically meaningful scale. GlycoVision is capable of producing a robust pipeline of powerful clinical applications, ranging from early disease screening to diagnostics and potentially therapeutics. The GlycoVision platform is accessible to industry partners seeking to discover novel biomarkers from as little as 50 µL of serum or plasma.
Investor and Board Member
Dec 2018
We are building AI to simulate the world through merging art and science.
We believe that world models are at the frontier of progress in artificial intelligence. Language models alone won’t solve the world’s hardest problems – robotics, disease, scientific discovery. Real progress requires models that experience the world and learn from their mistakes, the same way that humans do. And this kind of trial and error can be massively accelerated when done in simulation, rather than in the real world.
World models offer the most clear path to general-purpose simulation, changing how stories are told, how scientific progress is made and how the next frontiers of humanity are reached.
https://runwayml.com/world-simulator
Investor and Board Member
Nov 2017
Our mission is to build the Covariant Brain, a universal AI to give robots the ability to see, reason and act on the world around them. Bringing AI from research in the lab to the infinite variability and constant change of our customer’s real-world operations requires new ideas, approaches and techniques.
Success in the real world requires a team that represents that world: diversity of backgrounds, points of view, and experiences. Our common denominator: ambitious expectations, love of learning, empathy for those around us, and a team-first mindset.
Investor
Apr 2017
mabl is the enterprise SaaS leader of intelligent, low-code test automation that empowers high-velocity software teams to embed automated end-to-end tests into the entire development lifecycle. mabl customers benefit from a unified platform for easily creating, executing, and maintaining reliable browser, API and mobile web tests that result in faster delivery of high-quality, business critical applications. That’s why customer-centric brands like Charles Schwab, jetBlue, Dollar Shave Club, Stack Overflow, and many others rely on mabl to create the digital experiences their customers demand.
Investor and Board Member
Apr 2016
We help software vendors ship their apps to complex customer environments. Expand your market and reduce costs with one-line installs and updates to Kubernetes clusters anywhere.
Investor and Board Member
Oct 2015
We started Turbine Labs to help teams of all sizes move faster and more confidently. Whether you want to improve the iteration pace of your current architecture or rebuild it from scratch, we’ve got you covered.
Investor and Board Member
Sep 2015
Backtrace is the turn-key debugging platform that helps teams quickly figure out the when, where, and why behind application errors. Backtrace captures detailed dumps of failed application state, automates analysis of the data and highlights important classifiers, and archives this in a powerful database. All of this seamlessly plugs into your existing workflow tools like Slack, JIRA, PagerDuty and more. Improve your time to detection and resolution, increase your team’s efficiency, and take control of errors with Backtrace.
Investor and Board Member
Sep 2014
Enlitic is a medical intelligence company that believes in evolving patient care. Since 2014, we’ve developed technologies that improve how intelligence is used by eliminating inefficiencies in every stage of the clinical workflow.
Our products, innovations, insights, and solutions were all designed with Enlitic Intelligence – Intelligence designed around Collaboration, Adaptability, Relevance, Enlightenment. Or as we say, Intelligence that cares.
Join us as we transform healthcare through intelligence.
Show all 29 investments ↓
Experience · 34 entries
All (34)
Investments (32)
Founder (1)
Board (21)
2025
2024
Investor and Board Member
Oct 2024
Axiom helps scientists eliminate molecular toxicity by providing the most accurate and affordable predictive models. Our proprietary dataset includes more than 100,000 molecules tested in pooled primary human liver cells, tens of thousands of molecules with pharmacokinetic measurements, and thousands of molecules with curated clinical outcome data. Axioms AI models offer higher accuracy than advanced in vitro systems like 3d spheroids, deep mechanistic understanding which untangles mitochondrial toxicity, ER stress, ROS formation, cytotoxicity, and more, and precise risk assessment for any molecule at relevant clinical dosage and clinical exposure levels. Our models remove the need for costly physical experiments, giving more accurate and cheaper toxicity assessments, and empowering scientists to make better-informed decisions and bring safer drugs to the clinic.
2020
Investor and Board Member
Oct 2020
Your team is your best defense against attacks. Empower them to build safe, scalable access workflows.
Sym's approach to access management removes the pain of manual ticket queues and unmaintainable internal tools. Our low-code, DevOps-friendly workflow platform unlocks authorization tooling that is maintainable and highly customizable.
Investor and Board Member
May 2020
With Hex, anyone can explore data using natural language, with or without code, all on trusted context, in one AI-powered platform.
2019
Investor and Board Member
Dec 2019
Einblick is the fastest and most collaborative way to explore data, create predictions, and deploy data apps.
The Einblick team has joined Databricks https://www.databricks.com/blog/welcome-data-intelligence-platform-databricks-einblick
Show all 34 entries ↓
Investment activity
2002–2025 · 32 investments
Recent (last 2 years)Earlier
